A new drug improves liver function in patients who did not respond to conventional treatment

Lebanon 24: Results from an advanced clinical trial showed that Ipsen’s drug “Ikerfo” helped improve liver function in most patients with primary biliary cholangitis who did not achieve an adequate response to conventional treatment, according to Reuters. The study included 92 patients…
Machine translation of an attributed source excerpt. Consult the original report to verify details. Translated from original reporting in another language.

